Ledger.Open graph →

SEC Form D · Amendment · filed May 7, 2024

Iambic Therapeutics, Inc

Offering

$38.0M

Sold

$29.9M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

SAN DIEGO, CA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Kurt Von Emster · San Diego, CADirector Evan Rachlin · San Diego, CADirector Neil Josephson · San Diego, CAExec R. Jacob Vogelstein · San Diego, CADirector Fred Manby · San Diego, CAExec · Director Tabbert Teng · San Diego, CAExec Thomas Miller · San Diego, CAExec · Director William Rastetter · San Diego, CADirector Jishnu Bhattacharjee · San Diego, CADirector Evan Rachlin · San Diego, CADirector Jishnu Bhattacharjee · San Diego, CADirector Tabbert Teng · San Diego, CAExec Kurt Von Emster · San Diego, CADirector R. Jacob Vogelstein · San Diego, CADirector Fred Manby · San Diego, CAExec · Director Thomas Miller · San Diego, CAExec · Director Neil Josephson · San Diego, CAExec William Rastetter · San Diego, CADirector Darcy E. Higgs · Vancouver, British Columbia, CanadaExec · Director Sandra E. Mackay · Vancouver, British Columbia, CanadaDirector Todd E. Hilditch · Vancouver, British Columbia, CanadaDirector John E. E. Larson · Vancouver, British Columbia, CanadaExec Christina Blacker · Vancouver, British Columbia, CanadaExec · Director John R. Howard · Dallas, TXDirector Pat S. Bolin · Dallas, TXDirector Jon Myers · Charlottesville, VADirector Edward Rothschild · Seattle, WAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗